WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000029428) 5T4 TUMOUR-ASSOCIATED ANTIGEN FOR USE IN TUMOUR IMMUNOTHERAPY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/029428    International Application No.:    PCT/GB1999/003859
Publication Date: 25.05.2000 International Filing Date: 18.11.1999
Chapter 2 Demand Filed:    15.06.2000    
IPC:
A61K 48/00 (2006.01), C07K 14/47 (2006.01)
Applicants: OXFORD BIOMEDICA (UK) LIMITED [GB/GB]; Medawar Centre Robert Robinson Avenue The Oxford Science Park Oxford OX4 4GA (GB) (For All Designated States Except US).
CARROLL, Miles, William [GB/GB]; (GB) (For US Only).
MYERS, Kevin, Alan [GB/GB]; (GB) (For US Only)
Inventors: CARROLL, Miles, William; (GB).
MYERS, Kevin, Alan; (GB)
Agent: MASCHIO, Antonio; D Young & Co. 21 New Fetter Lane London EC4A 1DA (GB)
Priority Data:
9825303.2 18.11.1998 GB
9901739.4 27.01.1999 GB
9917995.4 30.07.1999 GB
Title (EN) 5T4 TUMOUR-ASSOCIATED ANTIGEN FOR USE IN TUMOUR IMMUNOTHERAPY
(FR) POLYPEPTIDE
Abstract: front page image
(EN)The present invention provides 5T4 tumour-associated antigen (TAA) for use in a method of immunotherapy of tumours. The invention also relates to a recombinant poxvirus vector from which at least one immune evasion gene has been deleted, which comprises a nucleic acid sequence encoding a 5T4 TAA and the use thereof in vaccinating against and in treating tumours.
(FR)Cette invention a trait à un antigène associé à une tumeur (TAA) 5T4 utilisé dans une méthode immunothérapique de traitement de tumeurs. Elle concerne également un vecteur poxviral de recombinaison dont au moins un gène d'évasion immune a été détruit, comprenant une séquence nucléotidique codant un TAA 5T4, ainsi que son utilisation en matière de vaccination antitumorale et de traitement de tumeurs.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)